Edition:
United Kingdom

Catalent Inc (CTLT.N)

CTLT.N on New York Stock Exchange

42.94USD
19 Jan 2018
Change (% chg)

$0.52 (+1.23%)
Prev Close
$42.42
Open
$42.44
Day's High
$42.94
Day's Low
$42.28
Volume
199,006
Avg. Vol
341,586
52-wk High
$43.42
52-wk Low
$25.71

Select another date:

Mon, Nov 6 2017

BRIEF-Catalent Q1 earnings per share $0.03

* Q1 earnings per share view $0.17 -- Thomson Reuters I/B/E/S

BRIEF-Catalent completes repricing and extension of credit agreement

* Catalent completes repricing and extension of credit agreement Source text for Eikon: Further company coverage:

BRIEF-Catalent announces pricing of private offering of senior unsecured notes due 2026

* Catalent announces pricing of private offering of senior unsecured notes due 2026

BRIEF-Catalent launches private offering of $450 mln of senior unsecured notes due 2026

* Catalent announces launch of private offering of $450 million of senior unsecured notes due 2026

BRIEF-Catalent Inc announces pricing of public offering

* Catalent Inc announces pricing of public offering of common stock to fund part of its acquisition of Cook Pharmica

BRIEF-Catalent announces public offering of common stock to fund part of its acquisition of Cook Pharmica

* Catalent Inc announces public offering of common stock to fund part of its acquisition of Cook Pharmica

BRIEF-Catalent files for common stock offering of upto $‍​250 million

* Catalent Inc - files for common stock offering of upto $‍​250.0 million- SEC Filing Source text:(http://bit.ly/2xGCzV4) Further company coverage:

Catalent bolsters biopharma business with Cook Pharmica buy

U.S. drug contract manufacturer Catalent Inc agreed to buy Cook Pharmica LLC for $950 million in cash as the company doubles down on its fast-growing business of supplying biologics to drugmakers.

UPDATE 2-Catalent bolsters biopharma business with Cook Pharmica buy

Sept 19 U.S. drug contract manufacturer Catalent Inc agreed to buy Cook Pharmica LLC for $950 million in cash as the company doubles down on its fast-growing business of supplying biologics to drugmakers.

Catalent to buy Cook Pharmica for $950 mln

Sept 19 U.S. drug delivery technology company Catalent Inc said on Tuesday it would buy privately held Cook Pharmica LLC for $950 million in cash.

Select another date: